BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9866002)

  • 1. Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom.
    Mascarenhas L; van Beek A; Bennink HC; Newton J
    Contraception; 1998 Oct; 58(4):215-9. PubMed ID: 9866002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
    Mascarenhas L; van Beek A; Bennink HC; Newton J
    Hum Reprod; 1998 Nov; 13(11):3057-60. PubMed ID: 9853856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.
    Biswas A; Viegas OA; Roy AC
    Contraception; 2003 Sep; 68(3):189-93. PubMed ID: 14561539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion and removal of Implanon.
    Mascarenhas L
    Contraception; 1998 Dec; 58(6 Suppl):79S-83S. PubMed ID: 10095977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
    Mäkäräinen L; van Beek A; Tuomivaara L; Asplund B; Coelingh Bennink H
    Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women.
    Singh K; Ratnam SS
    Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
    Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated analysis of nonmenstrual adverse events with Implanon.
    Urbancsek J
    Contraception; 1998 Dec; 58(6 Suppl):109S-115S. PubMed ID: 10095981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial.
    Egberg N; van Beek A; Gunnervik C; Hulkko S; Hirvonen E; Larsson-Cohn U; Bennink HC
    Contraception; 1998 Aug; 58(2):93-8. PubMed ID: 9773263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implanon contraceptive implants: effects on carbohydrate metabolism.
    Biswas A; Viegas OA; Coeling Bennink HJ; Korver T; Ratnam SS
    Contraception; 2001 Mar; 63(3):137-41. PubMed ID: 11368985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.
    Affandi B
    Contraception; 1998 Dec; 58(6 Suppl):99S-107S. PubMed ID: 10095980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
    Yao XY; Du MK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):419-22. PubMed ID: 12921554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A; Biswas S; Viegas OA
    Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.
    Wenzl R; van Beek A; Schnabel P; Huber J
    Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion and removal of Implanon: practical considerations.
    Mascarenhas L
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Implanon use on selected parameters of thyroid and adrenal function.
    Biswas A; Viegas OA; Bennink HJ; Korver T; Ratnam SS
    Contraception; 2000 Nov; 62(5):247-51. PubMed ID: 11172795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.